Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Enzolytics Inc. (ENZC)
OTHER OTC:ENZC
Holding ENZC?
Track your performance easily
ENZC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $0.03
Previous Close$0.01
Volume13.70M
Average Volume (3M)N/A
Market Cap
$4.49M
Enterprise Value$4.45M
Total Cash (Recent Filing)$7.90K
Total Debt (Recent Filing)$141.15K
Price to Earnings (P/E)―
Beta-0.57
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
May 23, 2012Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding3,661,644,157
10 Day Avg. Volume21,790,314
30 Day Avg. VolumeN/A
Standard Deviation1.49
R-Squared0.00122
Alpha0.28
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue96.48
Enterprise Value/Gross Profit120.26
Enterprise Value/Ebitda-0.69
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
ENZC FAQ
What was Enzolytics Inc.’s price range in the past 12 months?
Enzolytics Inc. lowest stock price was <$0.01 and its highest was $0.03 in the past 12 months.
What is Enzolytics Inc.’s market cap?
Currently, no data Available
When is Enzolytics Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Enzolytics Inc.’s earnings last quarter?
Currently, no data Available
Is Enzolytics Inc. overvalued?
According to Wall Street analysts Enzolytics Inc.’s price is currently Overvalued.
Does Enzolytics Inc. pay dividends?
Enzolytics Inc. pays a Notavailable dividend of $156.25 which represents an annual dividend yield of N/A. See more information on Enzolytics Inc. dividends here
What is Enzolytics Inc.’s EPS estimate?
Enzolytics Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Enzolytics Inc. have?
Enzolytics Inc. has 4,791,646,500 shares outstanding.
What happened to Enzolytics Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Enzolytics Inc.?
Currently, no hedge funds are holding shares in ENZC
---
Enzolytics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
8072.19%
Trailing 12-Months
Company Description
Enzolytics Inc.
Enzolytics, Inc. is a development stage company, which engages in the research and development on the operations and treatment of HIV/Aids virus. It focuses on the commercialization of the license rights of the IPF for the treatment of Aids and Hepatitis C as well as potential other treatments for life threatening diseases. The company was founded on July 28, 2004 and is headquartered in Monrovia, CA.
---
CytoDyn
―
Northwest Biotherapeutics
―
Inovio Pharmaceuticals
―
BioRestorative Therapies
―
---